Rosacea – S1 Guideline
- 6 May 2013
- journal article
- guideline
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 11 (8) , 768-780
Abstract
No abstract availableThis publication has 104 references indexed in Scilit:
- TLR2 Expression Is Increased in Rosacea and Stimulates Enhanced Serine Protease Production by KeratinocytesJournal of Investigative Dermatology, 2011
- Chitin Modulates Innate Immune Responses of KeratinocytesPLOS ONE, 2011
- STEROID - INDUCED ROSACEA: A CLINICAL STUDY OF 200 PATIENTSIndian Journal of Dermatology, 2011
- Topical Azithromycin Therapy for Meibomian Gland Dysfunction: Clinical Response and Lipid AlterationsCornea, 2010
- The molecular pathology of rosaceaJournal of Dermatological Science, 2009
- Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosaceaJournal of the American Academy of Dermatology, 2007
- Epidemiologic aspects of rosaceaJournal of the American Academy of Dermatology, 2005
- Rosacea: I. Etiology, pathogenesis, and subtype classificationJournal of the American Academy of Dermatology, 2004
- Tacrolimus effect on rosaceaJournal of the American Academy of Dermatology, 2004
- Rosacea: A study of clinical patterns, blood flow, and the role of Demodex folliculorumJournal of the American Academy of Dermatology, 1992